ReproNovo
ReproNovo is a clinical-stage biopharmaceutical company developing therapeutic solutions for male and female infertility and women's health conditions. Its pipeline includes RPN-002 (Nolasiban) for improving embryo implantation in IVF/ICSI procedures and RPN-001 (leflutrozole) for male fertility and adenomyosis management. The company targets patients requiring assisted reproductive technologies and those with low testosterone-related sperm production issues.
Visit websiteLausanne, Switzerland
Biotechnology
Pharmaceuticals
Healthtech
Reproductive Medicine
Funding summary
- Total raised
- €57.0M
- Funding rounds
- 1
Investors in ReproNovo
Investors on record for ReproNovo. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like ReproNovo?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors